Psybio Therapeutics Corp (PSYB)
TSXV
Year End December 30 2022 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 26k | 0 | 0 | 0 | 0 | 0 |
Operating Income | -87k | -128k | -73k | -52k | 0 | -19k | -6.52M | -2.69M |
Pre Tax Income | -87k | -128k | -73k | -52k | -28k | -53k | -11.02M | -4.89M |
Net Income | -87k | -128k | -73k | -52k | -28k | -22k | -11.02M | -4.89M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | -0.012 | -0.018 | -0.025 | -0.012 | -0.007 | -0.005 | -0.179 | -0.078 |
EBIT | -87k | -128k | -73k | -52k | 0 | -19k | -6.66M | -2.9M |
EBITDA | -87k | -128k | -73k | -52k | 0 | -19k | -6.52M | -2.54M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.